Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures

BACKGROUND AND OBJECTIVES: To evaluate long-term efficacy (percent seizure frequency reduction and responder rates), safety, and tolerability of adjunctive cenobamate (CNB) in an open-label extension (OLE) of the randomized, double-blind, placebo-controlled study. METHODS: Patients (aged 18–70 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Pavel, Aboumatar, Sami, Brandt, Christian, Dong, Fang, Krauss, Gregory L., Mizne, Sarah, Sánchez-Álvarez, Juan Carlos, Steinhoff, Bernhard J., Villanueva, Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519254/
https://www.ncbi.nlm.nih.gov/pubmed/35705501
http://dx.doi.org/10.1212/WNL.0000000000200792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519254/
https://www.ncbi.nlm.nih.gov/pubmed/35705501
http://dx.doi.org/10.1212/WNL.0000000000200792

Ejemplares similares